Drugs
The next era of psychedelics may be precision-designed states of consciousness
A look inside Mindstate Design Labs' effort to design drugs that reliably produce specific states of consciousness.
The exciting research that may cure Parkinson’s
GeneCode is developing a drug it hopes won't just alleviate Parkinson's symptoms but also protect and restore patient's neural health.
Pager panic: When beepers were infiltrating schools
Cities and schools once actually arrested students for carrying this dangerous technology.
Psychedelic drugs and the law: What’s next?
The push to legalize magic mushrooms, MDMA, LSD, and other hallucinogens is likely to heighten tensions between state and federal law.
Does caffeine harm your decision-making?
A small study showed caffeine lessens decision-making. While preliminary, it raises questions about caffeine affects our "higher" cognitive functions.
Professor Giles Yeo on making sense of anti-obesity drugs
Anti-obesity drugs have been in the news, and for good reason; they seem to work. Giles Yeo talks us through some misconceptions at play.
A new hydrogel offers the hope of ending daily injections for diabetes
Type-2 diabetes often involves an intense and exhausting treatment burden, with many injections over many days. That might be set to change.
Australia’s 30-year quest to unlock an ancient painkiller
A crocodile attack led to a 30-year partnership to develop a painkiller based on the Nyikina Mangala people's traditional knowledge.
Bad trips: Study examines the long-term adverse effects of psychedelic drugs
New research suggests that some users face long-term difficulties following psychedelic use, including emotional and social challenges.
The psychedelic DMT causes the brain to become hyperconnected, scans reveal
Researchers gave 20 healthy subjects potent, intravenous doses of the psychedelic DMT and observed their brains. Here's what they found.